Merck & Co. Inc. buy BiotechBee
Start price
08.11.22
/
70%
€100.60
Target price
31.01.25
€150.00
Performance (%)
5.77%
End price
05.05.23
€106.40
Summary
This prediction ended on 05.05.23 with a price of €106.40. With a performance of 5.77%, the BUY prediction by BiotechBee for Merck & Co. Inc. closed with a slight gain. Dividends of €0.68 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -0.339% | -0.339% | 11.787% |
| iShares Core DAX® | -1.785% | -1.250% | 11.664% |
| iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% |
| iShares Nikkei 225® | -4.028% | -3.746% | 17.142% |
| iShares S&P 500 | -1.969% | 0.307% | 25.617% |
According to BiotechBee what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Merck & Co. Inc. diskutieren
Buy mit Kursziel 150,0